Evidence map›Paper›PMID 42648769›Full record

ArticleBMJ open2026

Spatial clustering and transmission networks of multidrug-resistant tuberculosis in Rwanda: a national retrospective genomic and spatial epidemiological study.

Isabel Cuella-Martin, Francois Hakizayezu, Wim Mulders, Hosee Niyompano, Docteur Runyambo, Jelle Keysers, Willem B De Rijk, Yves Habimana Mucyo, Patrick Migambi, Claude Mambo Muvunyi and 5 more

Abstract read
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Isabel Cuella-MartinUnit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium isabelcma@usal.es.ORCID http://orcid.org/0000-0001-7543-3386
Francois HakizayezuNational Reference Laboratory Division, Rwanda Biomedical Center, Kigali, Rwanda.
Wim MuldersUnit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Hosee NiyompanoNational Reference Laboratory Division, Rwanda Biomedical Center, Kigali, Rwanda.
Docteur RunyamboNational Reference Laboratory Division, Rwanda Biomedical Center, Kigali, Rwanda.
Jelle KeysersUnit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Willem B De RijkUnit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Yves Habimana MucyoTuberculosis and Other Respiratory Diseases Division, Rwanda Biomedical Center, Kigali, Rwanda.ORCID http://orcid.org/0000-0001-6097-1405
Patrick MigambiTuberculosis and Other Respiratory Diseases Division, Rwanda Biomedical Center, Kigali, Rwanda.
Claude Mambo MuvunyiRwanda Biomedical Center, Kigali, Rwanda.
Conor J MeehanUnit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Bouke C de JongUnit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Leen RigoutsUnit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Jean Claude Semuto Ngabonziza *Research Innovation and Data Science Division, Rwanda Biomedical Center, Kigali, Rwanda.ORCID http://orcid.org/0000-0002-6075-5603
Ellen Mitchell *Unit of Mycobacterial Diseases and Neglected Tropical Disease, Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.ORCID http://orcid.org/0000-0002-2824-3499

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundApproximately 96% of rifampicin resistance/multidrug-resistant tuberculosis (RR/MDR-TB) cases in Rwanda result from direct transmission rather than acquired resistance. However, the nationwide spatial distribution and transmission dynamics of RR/MDR-TB remain poorly characterised. This study aims to analyse spatial patterns of RR/MDR-TB in Rwanda and explore relationships between spatial proximity and RR/MDR-TB strains' genetic relatedness.

methodsWe conducted a retrospective analysis of 249 confirmed RR-TB cases across Rwanda from 2017 to 2024, using the known geolocations of patients' residences. Spatial and space-time clustering was assessed using Kulldorff's scan statistics. Demographic and socioeconomic determinants were evaluated using multivariable regression. For 201 cases with whole-genome sequencing data, we performed transmission analysis using a 5-SNP threshold to define recent transmission clusters and investigated spatial relationships within genetically related strains.

resultsSignificant spatial clustering of RR/MDR-TB was identified in 21 sectors, mainly in Nyarugenge, southern Gasabo and western Kicukiro (relative risk: 10.06; p<0.001). Our multivariable analysis showed that population density is positively associated with case notification rates. Molecular analysis revealed 88.5% of cases belonged to genotype clusters defined using a 12-SNP threshold, with 73.6% forming clusters at a strict 5-SNP threshold. Spatial K-function analysis of the six major clusters revealed heterogeneous transmission patterns, characterised by both tightly clustered outbreaks and regional transmission networks that spanned administrative boundaries. Most clusters (5/6) extended beyond Kigali, indicating that transmission networks operate across administrative divides.

conclusionRR/MDR-TB in Rwanda shows significant spatial clustering with transmission occurring through both localised and regional networks. Integrating genomic and spatial data reveals transmission patterns that extend beyond household contacts and administrative boundaries. These findings underscore the need to implement geographically targeted interventions that address community-level transmission to control RR/MDR-TB in Rwanda effectively.

Indexed as

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantAdultCluster AnalysisFemaleHumansMaleRetrospective StudiesRwandaWhole Genome SequencingEpidemiologyPublic healthTuberculosis

Identifiers

PMID42648769
PMCPMC13536106

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.